Moderna is raising $2 billion in convertible debt to fund its cancer drug push
The biotech company will sell notes due 2032, with an option to raise an additional $300 million, days after its stock hit a multi-year high
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Moderna raises $2 billion in convertible notes for cancer vaccine finance.yahoo.com